One-shot radiation blast aims to zap liver tumors better
NCT ID NCT06362395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single, extremely high dose of radiation, guided by advanced MRI technology, can control liver tumors that have spread from other cancers better than the usual high dose. About 114 adults with up to 3 liver metastases will be randomly assigned to receive either the experimental ultra-high dose or standard high dose radiation in one session. The goal is to see which dose provides better tumor control with fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL SQUAMOUS CELL CARCINOMA WITH LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new test could reveal how radiation affects the liver
- A new clue in the fight against colorectal cancer recurrence?
- Can a four-pronged attack shrink liver tumors enough for surgery?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors